Scotia Capital’s VanEck Biotech ETF BBH Stock Holding History

Scotia Capital’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,186	Closed	-$210K	–	862
2024 Q3	$210K	Buy	+1,186	New	+$210K	﹤0.01%	769
2024 Q1	–	Sell	-1,428	Closed	-$236K	–	833
2023 Q4	$236K	Sell	1,428 -200	-12%	-$30.8K	﹤0.01%	710
2023 Q3	$254K	Hold	1,628	–	–	﹤0.01%	677
2023 Q2	$254K	Sell	1,628 -140	-8%	-$22.4K	﹤0.01%	686
2023 Q1	$287K	Sell	1,768 -200	-10%	-$32.4K	﹤0.01%	642
2022 Q4	$314K	Sell	1,968 -25	-1%	-$3.96K	﹤0.01%	633
2022 Q3	$281K	Hold	1,993	–	–	﹤0.01%	640
2022 Q2	$291K	Sell	1,993 -67	-3%	-$9.98K	﹤0.01%	659
2022 Q1	$334K	Buy	2,060 +52	+3%	+$8.42K	﹤0.01%	704
2021 Q4	$380K	Sell	2,008 -166	-8%	-$32K	﹤0.01%	685
2021 Q3	$439K	Sell	2,174 -1,330	-38%	-$279K	﹤0.01%	650
2021 Q2	$707K	Sell	3,504 -330	-9%	-$61.4K	0.01%	581
2021 Q1	$673K	Buy	3,834 +239	+7%	+$43.2K	0.01%	560
2020 Q4	$610K	Sell	3,595 -477	-12%	-$78.6K	0.01%	530
2020 Q3	$660K	Buy	4,072 +462	+13%	+$75.1K	0.01%	456
2020 Q2	$589K	Sell	3,610 -50	-1%	-$7.6K	0.01%	404
2020 Q1	$468K	Sell	3,660 -1,750	-32%	-$236K	0.01%	443
2019 Q4	$754K	Buy	5,410 +1,789	+49%	+$235K	0.01%	443
2019 Q3	$428K	Hold	3,621	–	–	0.01%	550
2019 Q2	$467K	Hold	3,621	–	–	0.01%	530
2019 Q1	$465K	Sell	3,621 -39	-1%	-$4.93K	0.01%	512
2018 Q4	$405K	Sell	3,660 -560	-13%	-$67.7K	0.01%	492
2018 Q3	$575K	Buy	4,220 +50	+1%	+$6.5K	0.01%	501
2018 Q2	$502K	Hold	4,170	–	–	0.01%	504
2018 Q1	$502K	Buy	4,170 +555	+15%	+$69.6K	0.01%	519
2017 Q4	$450K	Buy	3,615 +1,250	+53%	+$160K	0.01%	545
2017 Q3	$317K	Sell	2,365 -695	-23%	-$90.5K	﹤0.01%	596
2017 Q2	$384K	Sell	3,060 -440	-13%	-$53.1K	0.01%	512
2017 Q1	$417K	Buy	3,500 +450	+15%	+$52.6K	0.01%	546
2016 Q4	$328K	Hold	3,050	–	–	0.01%	642
2016 Q3	$351K	Buy	3,050 +320	+12%	+$36.5K	0.01%	628
2016 Q2	$280K	Sell	2,730 -180	-6%	-$19.2K	0.01%	606
2016 Q1	$302K	Buy	2,910 +640	+28%	+$66.7K	0.01%	556
2015 Q4	$288K	Hold	2,270	–	–	0.01%	679
2015 Q3	$259K	Sell	2,270 -580	-20%	-$76.8K	0.01%	670
2015 Q2	$378K	Buy	2,850 +65	+2%	+$8.64K	0.01%	585
2015 Q1	$361K	Buy	2,785 +355	+15%	+$44.6K	0.01%	487
2014 Q4	$280K	Hold	2,430	–	–	0.01%	512
2014 Q3	$257K	Hold	2,430	–	–	0.01%	521
2014 Q2	$232K	Sell	2,430 -8,573	-78%	-$768K	0.01%	509
2014 Q1	$1M	Buy	+11,003	New	+$1.07M	0.02%	297

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Scotia Capital's BBH Position: Q4 2024 in Review

Scotia Capital sold out of VanEck Biotech ETF (BBH) in Q4 2024, closing a stake of 1,186 shares — an estimated $210K sold.

Scotia Capital first reported a position in BBH in Q1 2014 and held it in 41 quarters. The position peaked at $1M in Q1 2014. 115 funds tracked by Wall St. Rank hold BBH as of Q4 2024.

Scotia Capital reported no remaining VanEck Biotech ETF position as of Q4 2024 after selling out during the quarter.
Scotia Capital sold 1,186 VanEck Biotech ETF shares in Q4 2024, an estimated $210K.
Scotia Capital first reported a position in VanEck Biotech ETF in Q1 2014 and held it in 41 quarters.
Scotia Capital's VanEck Biotech ETF position peaked at $1M in Q1 2014.
115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2024.

Based on Scotia Capital's 13F filing for Q4 2024, filed 13 Feb 2025.